We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
-14.49%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$304M
AUM Growth
-$52.6M
(-15%)
Cap. Flow
+$7.69M
Cap. Flow
% of AUM
2.53%
Top 10 Holdings %
Top 10 Hldgs %
59.64%
Holding
41
New
6
Increased
17
Reduced
13
Closed
3
Top Buys
| 1 |
Janux Therapeutics
JANX
|
+$13.6M |
| 2 |
TECX
Tectonic Therapeutic
TECX
|
+$13M |
| 3 |
argenx
ARGX
|
+$8.65M |
| 4 |
Intuitive Surgical
ISRG
|
+$7.74M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$7.33M |
Top Sells
| 1 |
Acadia Healthcare
ACHC
|
+$15.3M |
| 2 |
AbCellera Biologics
ABCL
|
+$13M |
| 3 |
BridgeBio Pharma
BBIO
|
+$13M |
| 4 |
Zimmer Biomet
ZBH
|
+$8.45M |
| 5 |
Schrodinger
SDGR
|
+$7.55M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKFT
1
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $33M | 10.85% |
1,314,898
+289,898
| +28% | +$7.33M |
|
2
MeiraGTx Holdings
MGTX
$1.16B
| $25M | 8.22% |
3,691,546
-699,291
| -16% | -$4.7M |
|
|
3
BridgeBio Pharma
BBIO
$16.2B
| $21.1M | 6.93% |
610,000
-385,000
| -39% | -$13M |
|
|
4
Janux Therapeutics
JANX
$978M
| $18.6M | 6.12% |
689,901
+360,133
| +109% | +$13.6M |
|
5
Roivant Sciences
ROIV
$25.1B
| $18.4M | 6.05% |
1,826,163
+326,163
| +22% | +$3.53M |
|
6
Mirum Pharmaceuticals
MIRM
$7.38B
| $15.5M | 5.08% |
343,326
-107,801
| -24% | -$5.08M |
|
7
Kura Oncology
KURA
$1.01B
| $13.7M | 4.51% |
2,078,315
+753,315
| +57% | +$5.87M |
|
8
ADC Therapeutics
ADCT
$163M
| $13.5M | 4.42% |
9,543,004
+28,004
| +0.3% | +$47.6K |
|
9
Zymeworks
ZYME
$1.81B
| $11.4M | 3.75% |
957,229
+137,229
| +17% | +$1.87M |
|
|
FOLD
10
DELISTED
Amicus Therapeutics
FOLD
| $11.3M | 3.7% |
1,379,383
+459,383
| +50% | +$4.25M |
|
11
Icon
ICLR
$13.3B
| $10.5M | 3.46% |
60,099
-24,901
| -29% | -$4.83M |
|
12
Rocket Pharmaceuticals
RCKT
$399M
| $9.87M | 3.24% |
1,480,000
+391,294
| +36% | +$3.87M |
|
|
13
Acadia Healthcare
ACHC
$2.97B
| $8.79M | 2.89% |
290,000
-402,000
| -58% | -$15.3M |
|
|
14
argenx
ARGX
$54B
| $8.11M | 2.66% |
+13,700
| New | +$8.65M |
|
|
15
Schrodinger
SDGR
$1.22B
| $7.6M | 2.5% |
385,000
-335,500
| -47% | -$7.55M |
|
16
Syndax Pharmaceuticals
SNDX
$2.08B
| $7.48M | 2.46% |
609,252
-10,748
| -2% | -$152K |
|
|
TECX
17
Tectonic Therapeutic
TECX
$613M
| $7.06M | 2.32% |
+398,885
| New | +$13M |
|
|
18
Intuitive Surgical
ISRG
$138B
| $6.93M | 2.28% |
+14,000
| New | +$7.74M |
|
19
Shattuck Labs
STTK
$647M
| $6.31M | 2.07% |
6,638,935
| – | – |
|
|
20
AbCellera Biologics
ABCL
$2.06B
| $6.28M | 2.06% |
2,815,652
-4,534,348
| -62% | -$13M |
|
21
Immunovant
IMVT
$8.19B
| $6.15M | 2.02% |
360,000
+54,477
| +18% | +$1.14M |
|
22
Prothena Corp
PRTA
$441M
| $5.05M | 1.66% |
408,122
-10,000
| -2% | -$141K |
|
23
LivaNova
LIVN
$4.36B
| $5M | 1.64% |
127,300
+57,300
| +82% | +$2.57M |
|
24
Haemonetics
HAE
$3.48B
| $4.16M | 1.37% |
65,400
+18,700
| +40% | +$1.27M |
|
|
BPMC
25
DELISTED
Blueprint Medicines
BPMC
| $3.23M | 1.06% |
36,512
-30,488
| -46% | -$2.97M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA